Deal Announcements

Entra Pharmaceuticals Receives Series A Financing

Friday, December 19, 2008 5:34:00 AM PDT | VentureDeal Staff

Waltham, Massachusetts  --  Stealthy pharmaceutical company Entra Pharmaceuticals (no website) has garnered $4.23 million in its first round of venture capital investment, according to a report in PE Hub.

Not much is known about the company, however Entra is believed to be developing various drug delivery technologies.

Investors in the round included Flybridge Capital Partners and North Bridge Venture Partners. The company did not disclose how it would use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1